Advantage Trust Company’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$200K Buy
786
+291
+59% +$67.8K 0.07% 65
2026
Q1
$121K Sell
495
-75
-13% -$17.5K 0.05% 52
2025
Q4
$118K Sell
570
-200
-26% -$39.5K 0.05% 52
2025
Q3
$143K Sell
770
-75
-9% -$12.8K 0.06% 71
2025
Q2
$129K Hold
845
0.06% 73
2025
Q1
$140K Sell
845
-136
-14% -$21.3K 0.08% 53
2024
Q4
$142K Buy
981
+230
+31% +$35.6K 0.08% 52
2024
Q3
$122K Sell
751
-31
-4% -$4.94K 0.08% 59
2024
Q2
$114K Hold
782
0.08% 61
2024
Q1
$124K Sell
782
-200
-20% -$31.8K 0.09% 61
2023
Q4
$154K Buy
+982
New +$151K 0.12% 51

Other funds holding JNJ

Advantage Trust Company's JNJ Position: Q2 2026 in Review

Advantage Trust Company increased its Johnson & Johnson (JNJ) stake by 59% in Q2 2026, buying an estimated $67.8K and bringing the position to 786 shares worth $200K. The position accounts for 0.07% of the portfolio, ranked #65.

Advantage Trust Company first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 1,664 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Advantage Trust Company held 786 shares of Johnson & Johnson worth $200K as of Q2 2026.
  • Advantage Trust Company bought 291 Johnson & Johnson shares in Q2 2026, an estimated $67.8K.
  • Johnson & Johnson made up 0.07% of Advantage Trust Company's portfolio in Q2 2026, its #65 holding.
  • Advantage Trust Company first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 1,664 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Advantage Trust Company's 13F filing for Q2 2026, filed 17 Jul 2026.